★★★★Verified
“Tenofovir TAF at $15/month vs $1,800 in the US — that part is just true. The HBV consult was an hour and the FibroScan, viral load and full panel came back the same week. Only minus is the international department was busy.”
肝病 · 肝移植 · 2026
Hepatology & Liver Transplant,
Beijing 302 · Renji · West China.
First-line antiviral therapy, cirrhosis multi-disciplinary care, living-donor and deceased-donor liver transplant. China’s 75 million HBV-infected adults underpin the deepest hepatology services globally.
★★★★★
4.5(2 verified reviews)
~75M
Chronic HBV adults
Largest national HBV cohort globally
WHO 2024
~$5
Generic TDF / month
Generic tenofovir disoproxil
Hospital pharmacy
LDLT
Living-donor transplant
Mature programmes at top centres
Centre-published
FibroScan
Standard of care
Transient elastography routine
International guideline
Procedures & pathways
What this specialty
covers in China.
🔥 Trending
Hepatitis B antiviral therapy
Read pathway →
Cirrhosis management
Fatty liver / MASH evaluation
FibroScan elastography
ERCP / EUS
🔥 Trending
Liver transplant (LDLT / DDLT)
Autoimmune hepatitis
Wilson’s / hereditary liver disease
Top centres
Reference and
Class A teaching hospitals.
Beijing · NHC
Beijing 302 Hospital (Fifth Medical Center, PLA General) 解放军总医院第五医学中心
National infectious disease and liver disease reference centre · highest HBV volume in China
Class A teaching
Shanghai
Renji Hospital, SJTU 仁济医院
Class A · large hepatology service · MDT cirrhosis · liver transplant centre
Class A teaching
Chengdu · NHC
West China Hospital 华西医院
Class A · large liver transplant volume · LDLT and DDLT depth
Class A teaching
Shanghai
Huashan Hospital 华山医院
Class A · strong infectious-disease and hepatology · transplant capable
Class A teaching
Centre comparison
At a glance.
Indicative starting price for this specialty: $2,500–95,000 all-in international-patient package, depending on procedure complexity and centre.
| Hospital | City | Tier | NHC | JCI | Strength |
|---|---|---|---|---|---|
| Beijing 302 Hospital (Fifth Medical Center, PLA General) 解放军总医院第五医学中心 | Beijing | Class A teaching | ✓ | — | National infectious disease and liver disease reference centre · highest HBV volume in China |
| Renji Hospital, SJTU 仁济医院 | Shanghai | Class A teaching | — | — | Class A · large hepatology service · MDT cirrhosis · liver transplant centre |
| West China Hospital 华西医院 | Chengdu | Class A teaching | ✓ | — | Class A · large liver transplant volume · LDLT and DDLT depth |
| Huashan Hospital 华山医院 | Shanghai | Class A teaching | — | — | Class A · strong infectious-disease and hepatology · transplant capable |
NHC = National Health Commission designation as National Clinical Research Centre / National Medical Centre / National Clinical Key Specialty. JCI = Joint Commission International accreditation. Class A teaching = 三级甲等, China’s top hospital tier.
Patient reviews
What patients say about hepatology & liver transplant in China.
★★★★★Verified
Living-donor liver transplant
“LDLT at Tianjin First Center — sister was the donor. Match workup, ethics review, surgery, ICU, all in 6 weeks. The transplant team has done thousands of these. Both of us are home and well.”
FAQ
Hepatology & Liver Transplant in China — answered.
- Why China for hepatology?
- Three reasons: (1) China hosts ~75 million chronic HBV-infected adults — the largest national HBV cohort globally — and Class A teaching hospitals run high-volume hepatology services with deep antiviral and cirrhosis experience; (2) tenofovir and entecavir are off-patent in China with multiple NMPA-approved generics — generic TDF $5/month, brand Vemlidy (TAF) $15/month vs $1,800/month US; (3) liver transplant programmes (Renji, West China, Beijing 302) have substantial living-donor experience with published outcomes within international benchmarks.
- What does liver transplant cost?
- Indicative all-in international-patient pricing for living-donor liver transplant (LDLT) at top Chinese centres: $65,000–95,000 including donor and recipient hospitalisation, operating-room time, immunosuppression through discharge, and bilingual report. Deceased-donor (DDLT) is similar or modestly higher. By comparison, US private-payer LDLT averages $400,000–600,000. Long-term immunosuppression continues post-discharge — we coordinate handover with your home hepatologist.
- Is HBV antiviral therapy life-long?
- For most chronic HBV patients, yes — per AASLD and EASL guidelines, treatment is typically life-long unless sustained HBeAg seroconversion with consolidation, or HBsAg loss, occurs. Stopping antivirals can trigger severe hepatitis flare and must be specialist-supervised. We see chronic HBV as a long-term partnership: initial in-person workup at a Class A centre, then annual re-evaluation with FibroScan and viral load.
Want a written centre-match shortlist
in 48 hours?
Tell us the clinical question and your travel window. We return two written centre-match shortlists for hepatology & liver transplant — including subspecialty fit, English-workflow status, and starting prices.